Donay, P., Nokin, M.-J., & Cataldo, D. (19 October 2023). Exposure to heated tobacco products alters the function of alveolar macrophages [Poster presentation]. EMDS. |
Donay, P., Nokin, M.-J., & Cataldo, D. (01 June 2023). Exposure to heated tobacco products alters the function of lung macrophages [Paper presentation]. Basic Science Award Glaxo SmithKline. |
  | Crake, R., Kiweler, N., Thiry, M., Peulen, O., Blomme, A., Meiser, J., Ambrogio, C., Santamaria, D., Cataldo, D., & Nokin, M.-J. (June 2023). Targeting metabolic adaptations in drug tolerant BRAFV600E mutant NSCLC [Poster presentation]. EACR 2023, Torino, Italy. |
 | Dube, G., Tiamiou, A., Bizet, M., Boumahd, Y., Gasmi, I., Crake, R., Bellier, J., Nokin, M.-J., Calonne, E., Deplus, R., Wissocq, T., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (31 March 2023). Methylglyoxal: a novel upstream regulator of DNA methylation. Journal of Experimental and Clinical Cancer Research, 42 (1), 78. doi:10.1186/s13046-023-02637-w  Peer reviewed |
 | Bendavid, G., Hubeau, C., Perin, F., Gillard, A., Nokin, M.-J., Carnet, O., Gerard, C., Noël, A., Lefèbvre, P., Rocks, N., & Cataldo, D. (05 January 2023). Role for the metalloproteinase ADAM28 in the control of airway inflammation, remodelling and responsiveness in asthma. Frontiers in Immunology, 13. doi:10.3389/fimmu.2022.1067779 Peer Reviewed verified by ORBi |
  | Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., Roncarati, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., & Janji, B. (2023). Enhancement of anti-tumor immunity through interference with glycation stress in breast cancer [Poster presentation]. GIGA day. |
Donay, P., Nokin, M.-J., & Cataldo, D. (04 October 2022). Modifications of pulmonary macrophages profile after exposure to heated tobacco products [Poster presentation]. EDT Immunology Day. |
Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (04 October 2022). Diesel particles exposure favors lung cancer progression through induction of an immunosuppressive microenvironment [Poster presentation]. EDT Immunology Day, Sart-Tilman, Belgium. |
Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (30 September 2022). Diesel particles exposure favors lung cancer progression through induction of an immunosuppressive microenvironment [Poster presentation]. BACR Ghent. |
Donay, P., Nokin, M.-J., & Cataldo, D. (09 September 2022). Modifications of pulmonary macrophages profile after exposure to heated tobacco products [Poster presentation]. Interuniversity phD day. |
Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (09 September 2022). Diesel particles exposure favors lung cancer progression through induction of an immunosuppressive microenvironment [Poster presentation]. EDT-BCMB, Namur, Belgium. |
Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (06 September 2022). Diesel particles exposure favors lung cancer progression through induction of an immunosuppressive microenvironment [Poster presentation]. GIGA Cancer Day 2022, Sart-Tilman, Belgium. |
Donay, P., Nokin, M.-J., & Cataldo, D. (06 September 2022). Modifications of pulmonary macrophages profile after exposure to heated tobacco products [Poster presentation]. GIGA DAY 2022. |
Donay, P., Nokin, M.-J., & Cataldo, D. (04 September 2022). Modifications of pulmonary macrophages function by heated tobacco products [Poster presentation]. ERS International Congress 2022, Barcelone, Spain. |
 | Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim Meriem, Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (September 2022). Immunosuppressive effect of methylglyoxal stress in breast cancer [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Belgium. |
Donay, P., Nokin, M.-J., & Cataldo, D. (29 June 2022). Metabolic modifications of pulmonary macrophages and their pro-tumoral phenotype after exposure to heated tobacco products [Poster presentation]. ISCaM 2022, Turin, Italy. |
Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (22 June 2022). Diesel particles exposure favors lung cancer progression through induction of an inflammatory microenvironment [Poster presentation]. EACR Congress 2022, Seville, Spain. |
 | Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim, M., Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (21 June 2022). Methylglyoxal reshapes breast tumor immune microenvironment [Poster presentation]. European association for cancer research congress 2022, Séville, Spain. |
Delhez, M.-L., Noël, A., Cataldo, D., & Nokin, M.-J. (25 May 2022). Diesel particles exposure favors lung cancer progression through induction of an immunosuppressive microenvironment [Paper presentation]. GSK Awards, Bruxelles, Belgium. |
 | Ricciuti, B., Son, J., Okoro, J. J., Mira, A., Patrucco, E., Eum, Y., Wang, X., Paranal, R., Wang, H., Lin, M., Haikala, H. M., Li, J., Xu, Y., Alessi, J. V., Chloeu, C., Redig, A. J., Kohler, J., Dholakia, K. H., Chen, Y., ... Ambrogio, C. (2022). Comparative analysis and isoform-specific therapeutic vulnerabilities of KRAS mutations in non-small cell lung cancer. Clinical Cancer Research. Peer Reviewed verified by ORBi |
 | Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim Meriem, Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (2022). Methylglyoxal regulates the recruitment of tumor-infiltrating immunosuppressive cells in breast cancer [Poster presentation]. PhD Day UNamur 2022, Belgium. |
 | Kaminski, H., Marseres, G., Yared, N., Nokin, M.-J., Pitard, V., Zouine, A., Garrigue, I., Loizon, S., Capone, M., Gauthereau, X., Mamani-Matsuda, M., Coueron, Duran, R. V., Pinson, B., Pellegrin, I., Thiébaut, R., Couzi, L., Merville, P., & Dechanet-Merville, J. (January 2022). mTOR Inhibitors Prevent CMV Infection through the Restoration of Functional αβ and γδ T cells in Kidney Transplantation. Journal of the American Society of Nephrology, 33 (1), 121-137. doi:10.1681/ASN.2020121753 Peer Reviewed verified by ORBi |
 | Tiamiou, A., Dube, G., Bizet, M., Bellier, J., Deplus, R., Nokin, M.-J., Wissocq, T., Gasmi, I., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (09 June 2021). Methylglyoxal Induces An Epigenetic Deregulation leading to the Silencing of Tumor-Suppressor Genes in Breast Cancer [Poster presentation]. EACR Congress, Innovative Cancer Science, Better Outcomes through Resarch. |
 | Nguyen, T. L.* , Nokin, M.-J.* , Teres, S., Tome, M., Bodineau, C., Galmar, O., Pasquet, J.-M., Roussea, B., van Liempd, S., Falcon-Perez, J. M., Richard, E., Muzotte, E., Rezvani, H.-R., Priault, M., Bouchecareilh, M., Redonnet-Vernhet, I., Calvo, J., Uzan, B., Pflumio, F., ... Duran, R. V. (May 2021). Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia. Molecular Oncology, 15 (5), 1412-1431. doi:10.1002/1878-0261.12877 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
  | Nokin, M.-J., Ambrogio, C., Nadal, E., & Santamaria, D. (May 2021). Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer. Trends in Cancer, 7 (5), 410-429. doi:10.1016/j.trecan.2020.11.005 Peer Reviewed verified by ORBi |
 | Hubert, P., RONCARATI, P., Demoulin, S., Pilard, C., Ancion, M., Reynders, C., Lerho, T., Bruyère, D., Lebeau, A., Radermecker, C., Meunier, M., Nokin, M.-J., Hendrick, E., Peulen, O., Delvenne, P., & Herfs, M. (2021). Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Journal for ImmunoTherapy of Cancer, 9 ((3)), 001966. doi:10.1136/jitc-2020-001966 Peer Reviewed verified by ORBi |
Wissocq, T., Hubert, P., Caprasse, M., Nokin, M.-J., Noman, M. Z., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (07 February 2020). Methylglyoxal stress contributes to immunosuppression in breast cancer [Poster presentation]. Association Belge pour l'Etude du Cancer "A.B.E.C", Bruxelles, Belgium. |
 | Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012 Peer Reviewed verified by ORBi |
 | Nokin, M.-J., Darbo, E., Travert, C., Drogat, B., Lacouture, A., San José, S., Cabrera, N., Turcq, B., Prouzet-Mauleon, V., Falcone, M., Villanueva, A., Wang, H., Herfs, M., Mosteiro, M., Jänne, P. A., Pujol, J.-L., Maraver, A., Barbacid, M., Nadal, E., ... Ambrogio, C. (2020). Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma. JCI Insight. doi:10.1172/jci.insight.137869 Peer Reviewed verified by ORBi |
Nokin, M.-J. (17 October 2019). Targeting acquired vulnerabilities in Dabrafenib and Trametinib resistant BRAFV600E mutants LUAD [Paper presentation]. Chemistry meets Biology seminar, Bordeaux, France. |
 | Nokin, M.-J., Bellier, J., Durieux, F., Peulen, O., Rademaker, G., Gabriel, M., Monseur, C., CHARLOTEAUX, B., Verbeke, L., van Laere, S., RONCARATI, P., Herfs, M., Lambert, C., Scheijen, J., Schalkwijk, C., Colige, A., Caers, J., Delvenne, P., Turtoi, A., ... Bellahcene, A. (2019). Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Breast Cancer Research, 21(1, 11. doi:10.1186/s13058-018-1095-7 Peer Reviewed verified by ORBi |
 | Bellier, J., Nokin, M.-J., Lardé, E., Karoyan, P., Peulen, O., Castronovo, V., & Bellahcene, A. (2019). Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer. Diabetes Research and Clinical Practice. doi:10.1016/j.diabres.2019.01.002 Peer Reviewed verified by ORBi |
 | Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journe, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (26 November 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. Metabolism in cancer and Stromal Cells, Louvain, Belgium. |
 | Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journé, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (28 September 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. 3rd symposium of ULB - Cancer Research Center (U-CRC), Bruxelles, Belgium. |
Nokin, M.-J. (20 September 2018). A novel mechanism of mTOR inhibition displacing phosphatidic acid induces enhanced cytotoxicity specifically in cancer cells [Paper presentation]. Chemistry meets Biology seminar, Bordeaux, France. |
 | Nguyen, T. L., Nokin, M.-J., Egorov, M., Tomé, M., Bodineau, C., Di Primo, C., Minder, L., Wdzieczak-Bakala, J., Garcia-Alvarez, M. C., Bignon, J., Thoison, O., Delpech, B., Surpateanu, G., Frapart, Y.-M., Peyrot, F., Abbas, K., Terès, S., Evrard, S., Khatib, A.-M., ... Collin, P. (15 September 2018). mTOR inhibition via displacement of phosphatidic acid induces enhanced cytotoxicity specifically in cancer cells. Cancer Research, 78 (18), 5384-5397. doi:10.1158/0008-5472.CAN-18-0232 Peer Reviewed verified by ORBi |
 | Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journé, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (13 September 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. GIGA-Cancer Day 2018/EDT Cancerology, Liège, Belgium. |
Nokin, M.-J. (02 July 2018). Dual role of Methylglyoxal, a glycolysis side-product, in cancer [Poster presentation]. 25th Biennial Congress Of The European Association For Cancer Research, Amsterdam, Netherlands. |
 | Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Herfs, M., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (01 July 2018). Myoferlin controls mitochondrial structure and metabolism in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. EACR 25 50 Years, Amsterdam, Netherlands. |
Bellier, J., Nokin, M.-J., Durieux, F., Journe, F., Ghanem, G., Castronovo, V., & Bellahcene, A. (30 June 2018). Methylglyoxal-induced Dicarbonyl Stress: Role in Melanoma Progression and Response to Therapy [Poster presentation]. Bellier, Amsterdam, Netherlands. |
Nokin, M.-J. (24 May 2018). Methylglyoxal stress is associated with major ECM changes and the activation of MEK/ERK/SMAD1 signaling in highly metastatic breast cancer cells [Paper presentation]. Young Scientist Symposium, Bordeaux, France. |
Nokin, M.-J. (22 May 2018). A novel mechanism of mTOR inhibition displacing phosphatidic acid induces enhanced cytotoxicity specifically in cancer cells [Poster presentation]. TOR de France meeting, Nice, France. |
Nokin, M.-J. (22 May 2018). A novel mechanism of mTOR inhibition displacing phosphatidic acid induces enhanced cytotoxicity specifically in cancer cells [Paper presentation]. TOR de France meeting, Nice, France. |
 | Rademaker, G., Hennequière, V., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (April 2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene, 37 ((32)), 4398-4412. doi:10.1038/s41388-018-0287-z Peer Reviewed verified by ORBi |
Bellier, J., Nokin, M.-J., Durieux, F., Peulen, O., Koji, U., Spiegel A, Cochrane R, Hutton A, C., Castronovo, V., & Bellahcene, A. (27 January 2018). Hormetic potential of Methylglyoxal in switching cancer cells from growth to death [Poster presentation]. Bellier, Liège, Belgium. |
 | Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., Bellier, J., Costanza, B., Herfs, M., Bettendorff, L., Deroanne, C., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma and affects tumor aggressiveness [Poster presentation]. Bioforum Uliège. |
 | Bellahcene, A., Nokin, M.-J., Castronovo, V., & Schalkwijk, C. (2018). Methylglyoxal-derived stress: an emerging biological factor involved in the onset and progression of cancer. Seminars in Cancer Biology. doi:10.1016/j.semcancer.2017.05.010 Peer Reviewed verified by ORBi |
 | Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Anania, S., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic cancer and affects tumor aggressiveness [Poster presentation]. Belgian Association for Cancer Research Congress. |
Nokin, M.-J. (20 October 2017). Methylglyoxal, a glycolysis side-product, increases the metastatic potential of human breast cancer cells [Paper presentation]. ISCaM annual meeting 2017, Bertinoro, Italy. |
Bellier, J., Nokin, M.-J., Durieux, F., Peulen, O., Uchida, K., Spiegel A, D., Cochrane R, J., Hutton A, C., Castronovo, V., & Bellahcene, A. (19 October 2017). Hormetic potential of Methylglyoxal in switching cancer cells from growth to death [Poster presentation]. Bellier, Bertinoro, Italy. |
 | Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (22 September 2017). Myoferlin controls mitochondrial structure in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. Second U-CRC Symposium, Bruxelles, Belgium. |
Nokin, M.-J. (24 February 2017). Methylglyoxal-induced carbonyl stress: perspectives of a new anti-GBM therapy [Paper presentation]. Télévie Glioblastoma Seminar. |
Nokin, M.-J. (01 February 2017). Methylglyoxal, a glycolysis side-product, increases the metastatic potential of human breast cancer cells [Poster presentation]. GIGA-Day 2017. |
Nokin, M.-J. (28 January 2017). Methylglyoxal, a glycolysis side-product, increases the metastatic potential of human breast cancer cells [Poster presentation]. BACR meeting 2017. |
 | Chiavarina, B., Nokin, M.-J., Bellier, J., Durieux, F., BLETARD, N., Sherer, F., LOVINFOSSE, P., Peulen, O., Verset, L., Dehon, R., Demetter, P., Turtoi, A., Uchida, K., Goldman, S., Hustinx, R., Delvenne, P., Castronovo, V., & Bellahcene, A. (2017). Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer. International Journal of Molecular Sciences, 18 (1). doi:10.3390/ijms18010213 Peer Reviewed verified by ORBi |
 | Nokin, M.-J., Durieux, F., Bellier, J., Peulen, O., Uchida, K., Spiegel, D. A., Cochrane, J. R., Hutton, C. A., Castronovo, V., & Bellahcene, A. (2017). Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death. Scientific Reports, 7 (1), 11722. doi:10.1038/s41598-017-12119-7 Peer Reviewed verified by ORBi |
Nokin, M.-J. (27 October 2016). Methylglyoxal, a glycolysis side-product, increases the metastatic potential of human breast cancer cells [Poster presentation]. ISCAM 2016. |
 | Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Scheijen, J., Schalkwijk, C., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., ... Bellahcene, A. (2016). Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP- mediated tumor growth and metastasis. eLife. doi:10.7554/eLife.19375 Peer Reviewed verified by ORBi |
 | Nokin, M.-J. (2016). Role of carbonyl stress in breast cancer progression and metastases development [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/314907 |
 | Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483 Peer Reviewed verified by ORBi |
Nokin, M.-J. (22 April 2016). Methylglyoxal, a glycolysis side-product, increases the metastatic potential of human breast cancer cells [Poster presentation]. New frontiers in oxidative stress and redox regulation - FNRS contact group "Oxidative processes and antioxidants". |
 | Henry, A., Nokin, M.-J., Leroi, N., LALLEMAND, F., Lambert, J., Goffart, N., Peixoto, P., Blomme, A., BIANCHI, E., Habraken, Y., RONCARATI, P., Peulen, O., SCHOLTES, F., MARTINIVE, P., Rogister, B., Delvenne, P., Turtoi, A., Castronovo, V., & Bellahcene, A. (22 March 2016). Osteopontin predicts radiotherapy response of glioblastoma patients : new role in DNA damage repair [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gand, Belgium. |
Nokin, M.-J. (03 December 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Séminaire des chercheurs Télévie 2016. |
Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., Hutton, C., De Pauw, E., ... Bellahcene, A. (29 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Cancer and Metabolism Conference, Cambridge, United Kingdom. |
 | Durieux, F., Peixoto, P., Chiavarina, B., Nokin, M.-J., Karoyan, P., Castronovo, V., & Bellahcene, A. (28 September 2015). Characterization of new carbonyl scavenger molecules and their subsequent use for cancer therapy [Poster presentation]. Cancer and Metabolism Abcam 2015 Conference, Cambridge, United Kingdom. |
Nokin, M.-J. (11 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Paper presentation]. EDT annual mini symposium 2015 "New advances in animal models in cancerology", Namur, Belgium. |
Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Smargiasso, N., De Tullio, P., BIANCHI, E., Baiwir, D., Thiry, M., Turtoi, A., De Pauw, E., DELVENNE, P., Castronovo, V., & Bellahcene, A. (09 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Metabolism in Cancer and Stromal Cells, Leuven, Belgium. |
Nokin, M.-J. (13 May 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Paper presentation]. GIGA-Cancer Day 2015, Liège, Belgium. |
Nokin, M.-J. (11 February 2015). Accumulation of Methylglyoxal, a glycolysis by-product, modulates YAP1 transcription co-factor localization and activity in human breast cancer cells through HSP90 modification [Poster presentation]. Séminaire des chercheurs Télévie 2015. |
 | Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Smargiasso, N., Baiwir, D., De Pauw, E., De Tullio, P., Thiry, M., Peulen, O., Turtoi, A., Castronovo, V., & Bellahcene, A. (27 January 2015). Accumulation of methylglyoxal, a glycolysis by-product modulates YAP1 transcription co-factor localization and activity in human breast cancer cells through HSP90 modification [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium. |
 | Lamour, V., Henry, A., Kroonen, J., Nokin, M.-J., von Marschall, Z., Fisher, L., Chau, T.-L., Chariot, A., Sanson, M., Delattre, J.-Y., Turtoi, A., Peulen, O., Rogister, B., Castronovo, V., & Bellahcene, A. (2015). Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. International Journal of Cancer. doi:10.1002/ijc.29454 Peer Reviewed verified by ORBi |
Nokin, M.-J. (30 September 2014). Downregulation of HSP90 by Methylgyoxal, a glycolysis by-product, is associated with YAP1 accumulation in breast cancer cells [Poster presentation]. EDT annual mini symposium 2014. |
 | Chiavarina, B.* , Nokin, M.-J.* , Durieux, F., BIANCHI, E., Turtoi, A., Peulen, O., Peixoto, P., Irigaray, P., Uchida, K., Belpomme, D., Delvenne, P., Castronovo, V., & Bellahcene, A. (2014). Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes. Oncotarget. doi:10.18632/oncotarget.2121 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Nokin, M.-J. (19 May 2014). Glycation of YAP1 transcription factor by Methylglyoxal, a glycolysis by-product, induces its nuclear accumulation in human breast cancer cells [Poster presentation]. GIGA-Cancer Day 2014. |
Nokin, M.-J. (05 December 2013). Triple negative human breast cancers accumulate significantly less Arg-pyrimidine moieties, methylglyoxal specific adducts, than other subtype lesions [Poster presentation]. Séminaire des chercheurs Télévie 2014. |
Nokin, M.-J. (13 September 2013). Role of methylglyoxal, a side-product of glycolysis, in human breast cancer [Paper presentation]. EDT annual mini symposium 2013. |
Nokin, M.-J. (17 May 2013). Role of Dentin Matrix Protein 1 (DMP1) in human breast cancer progression [Poster presentation]. GIGA-Cancer Day 2013. |
 | Lamour, V., Nokin, M.-J., Henry, A., Castronovo, V., & Bellahcene, A. (2013). Les proteines SIBLING - Outils moleculaires de la progression tumorale et de l'angiogenese. MS. Medecine Sciences, 29 (11), 1018-25. doi:10.1051/medsci/20132911019 Peer Reviewed verified by ORBi |
Nokin, M.-J. (12 December 2012). Glucose-Regulated Protein 78 (GRP78): a potential cell surface receptor to Dentin Matrix Protein (DMP1) in human cancer cells? [Poster presentation]. Séminaire des chercheurs Télévie 2013. |
